These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 910465)

  • 1. The disposition and metabolism of 3',4',7-tri-O-(beta-hydroxyethyl)rutoside and 7-mono-O-(beta-hydroxyethyl)rutoside in the mouse.
    Hackett AM; Griffiths LA
    Xenobiotica; 1977 Oct; 7(10):641-51. PubMed ID: 910465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic clearance and disposition of hydroxyethylrutosides.
    Griffiths LA; Hackett AM
    Arch Toxicol Suppl; 1978; (1):243-6. PubMed ID: 277108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of hydroxyethylrutosides (HR): metabolism of [14C]-HR in man.
    Hackett AM; Griffiths LA; Luyckx AS; van Cauwenberge H
    Arzneimittelforschung; 1976; 26(5):925-8. PubMed ID: 989368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolism and excretion of 7-mono-0-(beta-hydroxyethyl) rutoside in the dog.
    Hackett AM; Griffiths LA
    Eur J Drug Metab Pharmacokinet; 1979; 4(4):207-12. PubMed ID: 535600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrophotofluorometric analysis of 3',4',7-tris[O-(beta-hydroxyethyl)]rutoside in urine.
    Tan HS; Mowery PJ; Ritschel WA; Neu C
    J Pharm Sci; 1978 Aug; 67(8):1142-4. PubMed ID: 671254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation and inhibition of biosynthesis of prostaglandins in human skin by some hydroxyethylated rutosides.
    Arturson G; Jonsson CE
    Prostaglandins; 1975 Dec; 10(6):941-8. PubMed ID: 1208886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tri- and tetra-O-(beta-hydroxyethyl)-rutoside on red blood cell aggregation of human blood.
    van Haeringen NJ
    Bibl Anat; 1975; 13():197-9. PubMed ID: 1231726
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism and pharmacokinetics of hydroxyethylated rutosides in animals and man.
    Balant LP; Wermeille M; Griffiths LA
    Q Rev Drug Metab Drug Interact; 1984; 5(1):1-24. PubMed ID: 6397783
    [No Abstract]   [Full Text] [Related]  

  • 9. o-(beta-Hydroxyethyl)-rutoside-mediated protection of renal injury associated with cis-diamminedichloroplatinum(II)/hyperthermia treatment.
    Bull JM; Strebel FR; Sunderland BA; Bulger RE; Edwards M; Siddik ZH; Newman RA
    Cancer Res; 1988 Apr; 48(8):2239-44. PubMed ID: 3349489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the metabolites of the antioxidant flavonoid 7-mono-O-(β-hydroxyethyl)-rutoside in mice.
    Jacobs H; Peters R; den Hartog GJ; van der Vijgh WJ; Bast A; Haenen GR
    Drug Metab Dispos; 2011 May; 39(5):750-6. PubMed ID: 21266594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of individual hydroxyethyl rutosides in various animal body fluids by thin-layer chromatography and scanning densitometry.
    Hackett AM; Niebes P; Griffiths LA
    J Chromatogr; 1978 Feb; 148(2):469-75. PubMed ID: 621266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies in animal experiments on determination of blood and organ levels of o-(beta-hydroxyethyl)-rutosides (HR) after i.p. administration (author's transl)].
    Reinartz G; Wurst F
    Arzneimittelforschung; 1980; 30(4):657-9. PubMed ID: 7190409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HPLC determination of troxerutin in plasma and urine following oral administration in man].
    Dittrich P; Ostrowski J; Beubler E; Schraven E; Kukovetz W
    Arzneimittelforschung; 1985; 35(4):765-7. PubMed ID: 4015744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of the hydroxyethylrutosides. Biliary and urinary excretion of 3',4',5-(hydroxyethyl- 14 C), 7-tetra-O-( -hydroxyethyl)-rutoside in rats and monkeys after parenteral administration.
    Barrow A; Griffiths LA
    Xenobiotica; 1972 Nov; 2(6):575-86. PubMed ID: 4197021
    [No Abstract]   [Full Text] [Related]  

  • 15. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of the hydroxyethylrutosides. II. Excretion and metabolism of 3',4',7-tri-O-(beta-hydroxyethyl) rutoside and related compounds in laboratory animals after parenteral administration.
    Barrow A; Griffiths LA
    Xenobiotica; 1974 Jan; 4(1):1-16. PubMed ID: 4207896
    [No Abstract]   [Full Text] [Related]  

  • 18. Disposition and metabolism of [14C]-amezinium metilsulfate in rats.
    Nambu K; Yoshida K; Kagemoto A; Matsumoto K; Miyazaki H; Hashimoto M; Esumi Y; Jin Y; Gunji S; Iwabuchi M
    Arzneimittelforschung; 1988 Jul; 38(7):909-18. PubMed ID: 3207436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of mono-3'- and mono-4'-0-(beta-hydroxyethyl)-rutoside derivatives, after single doses of Venoruton powder in healthy volunteers.
    Kienzler JL; Sallin D; Schifflers MH; Ghika A
    Eur J Clin Pharmacol; 2002 Sep; 58(6):395-402. PubMed ID: 12242598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The flavonoid 7-mono-O-(β-hydroxyethyl)-rutoside is able to protect endothelial cells by a direct antioxidant effect.
    Lemmens KJ; van de Wier B; Vaes N; Ghosh M; van Zandvoort MA; van der Vijgh WJ; Bast A; Haenen GR
    Toxicol In Vitro; 2014 Jun; 28(4):538-43. PubMed ID: 24412621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.